Aurinia Pharmaceuticals (AUPH) Inventory (2020 - 2026)

Aurinia Pharmaceuticals (AUPH) has 7 years of Inventory data on file, last reported at $46.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory changed 0.47% year-over-year to $46.4 million; the trailing twelve-month figure through Mar 2026 stood at $46.4 million (changed 0.47% YoY), and the FY2025 full-year result was $45.7 million, up 16.47% from the prior year.
• Inventory for Q1 2026 stood at $46.4 million, up from $45.7 million in the prior quarter.
• Across five years, Inventory topped out at $46.5 million in Q2 2025 and bottomed at $24.8 million in Q4 2022.
• The 5-year median for Inventory is $38.9 million (2024), against an average of $36.8 million.
• The widest annual swing landed in 2022, when Inventory surged 64.82%; it then decreased 1.2% in 2024.
• A 5-year view of Inventory shows it stood at $24.8 million in 2022, then jumped by 60.41% to $39.7 million in 2023, then dropped by 1.2% to $39.2 million in 2024, then rose by 16.47% to $45.7 million in 2025, then increased by 1.58% to $46.4 million in 2026.
• The last three Inventory figures came in at $46.4 million (Q1 2026), $45.7 million (Q4 2025), and $44.8 million (Q3 2025), per Business Quant data.

Peer Comparison